Skip to content
Back to SYRE

Spyre Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
94
Purchases
0
Sales
94
Purchase value
$0.00
Sale value
$441.93M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Heidy King-JonesSee Remarks
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Oct 1, 20260001636282-26-000119
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF1F2400$89.24$35.70K31,378Direct
SaleOct 1, 2026
Common StockF1F316,605$90.35$1.50M14,773Direct
SaleOct 1, 2026
Common StockF1F47,228$91.35$660.28K7,545Direct
SaleOct 1, 2026
Common StockF1F52,100$92.70$194.67K5,445Direct
SaleOct 1, 2026
Common StockF1F62,600$93.46$243.00K2,845Direct
Filing footnotes · 7
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.96 to $90.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.10 to $92.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.12 to $93.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.17 to $93.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7This option represents the right to purchase 539,810 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Oct 1, 20260001636282-26-000118
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF1F2F3600$89.14$53.48K551,940Direct
SaleOct 1, 2026
Common StockF1F4F32,683$90.10$241.74K549,257Direct
SaleOct 1, 2026
Common StockF1F5F32,638$91.49$241.35K546,619Direct
SaleOct 1, 2026
Common StockF1F6F33,989$92.31$368.22K542,630Direct
SaleOct 1, 2026
Common StockF1F7F34,990$93.37$465.92K537,640Direct
SaleOct 1, 2026
Common StockF1F3100$93.91$9.39K537,540Direct
Filing footnotes · 7
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 29,078 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.80 to $90.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.85 to $91.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.87 to $92.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.89 to $93.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Oct 2, 2026Period of report Sep 30, 20260001636282-26-000117
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 1, 2026
Common StockF2F3600$89.07$53.44K86,662Direct
SaleOct 1, 2026
Common StockF2F41,500$90.27$135.41K85,162Direct
SaleOct 1, 2026
Common StockF2F52,100$91.92$193.03K83,062Direct
SaleOct 1, 2026
Common StockF2F63,071$92.95$285.45K79,991Direct
SaleOct 1, 2026
Common StockF2F7F8229$93.57$21.43K79,762Direct
SaleSep 30, 2026
Common StockF117,500$89.89$1.57M79,762Direct
Filing footnotes · 9
  1. F1The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.00 to $90.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  2. F2This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.63 to $89.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.96 to $90.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.41 to $92.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.54 to $93.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.54 to $93.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. F8Includes 33,738 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. The RSUs vest on September 1, 2027, subject to the Reporting Person's continued employment with the Issuer.
  9. F9This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Heidy King-JonesSee Remarks
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001636282-26-000111
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 2, 2026
Common StockF1F2400$90.00$36.00K2,845Direct
SaleSep 1, 2026
Common StockF1F3F24,845$86.40$418.61K25,999Direct
SaleSep 1, 2026
Common StockF1F4F216,548$87.20$1.44M9,451Direct
SaleSep 1, 2026
Common StockF1F5F26,206$88.17$547.18K3,245Direct
SaleSep 1, 2026
Common StockF1F2400$89.38$35.75K2,845Direct
Filing footnotes · 6
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  2. F2Includes 489 shares of common stock acquired by the Reporting Person on August 15, 2024, 495 shares of common stock acquired by the Reporting Person on February 15, 2025, 850 shares of common stock acquired by the Reporting Person on August 15, 2025, 325 shares of common stock acquired by the Reporting Person on December 31, 2025, and 686 shares of common stock acquired by the Reporting Person on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.71 to $86.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.71 to $87.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.73 to $88.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6This option represents the right to purchase 539,810 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001636282-26-000109
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 2, 2026
Common StockF6F718,232$89.35$1.63M79,762Direct
SaleSep 1, 2026
Common StockF1F2900$86.25$77.63K104,594Direct
SaleSep 1, 2026
Common StockF1F34,384$87.11$381.89K100,210Direct
SaleSep 1, 2026
Common StockF1F42,016$88.03$177.47K98,194Direct
SaleSep 1, 2026
Common StockF1F5200$89.04$17.81K97,994Direct
Filing footnotes · 8
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.60 to $86.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.60 to $87.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.64 to $88.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.69 to $89.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The transaction reported reflects the sale of shares of the Issuer's common stock in satisfaction of the Reporting Person's tax liability in connection with the settlement of 33,738 restricted stock units ("RSUs"). This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade made by the Reporting Person.
  7. F7Includes 33,738 RSUs. Each RSU represents a contingent right to receive, upon vesting, one share of the Issuer's common stock. The RSUs vest on September 1, 2027, subject to the Reporting Person's continued employment with the Issuer.
  8. F8This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Sep 3, 2026Period of report Sep 1, 20260001636282-26-000107
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 1, 2026
Common StockF1F2F32,500$86.36$215.90K565,040Direct
SaleSep 1, 2026
Common StockF1F4F38,400$87.15$732.06K556,640Direct
SaleSep 1, 2026
Common StockF1F5F33,700$88.06$325.82K552,940Direct
SaleSep 1, 2026
Common StockF1F6F3400$89.07$35.63K552,540Direct
Filing footnotes · 6
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.67 to $86.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 43,593 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.67 to $87.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.68 to $88.67, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.69 to $89.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Jeffrey W. AlbersDirector
4Rule 10b5-1 plan disclosed
Filed Aug 10, 2026Period of report Aug 7, 20260001636282-26-000102
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 7, 2026
Common StockF1F25,000$104.47$522.35K0Direct
SaleAug 7, 2026
Common StockF1F38,000$104.38$835.04K19,360IndirectBy Sessions LLC
SaleAug 7, 2026
Common StockF1F410,000$104.68$1.05M9,360IndirectBy Sessions LLC
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on April 16, 2026.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.59 to $105.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.52 to $105.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.60 to $106.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5This option represents a right to purchase 50,000 shares of the Issuer's common stock, which vest and become exercisable in 36 equal monthly installments beginning on November 22, 2023 until such time as the option is 100% vested, subject to the Reporting Person's continuous service with the Issuer at each vesting date.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001636282-26-000100
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF1F25,100$95.21$485.57K100,394Direct
SaleAug 3, 2026
Common StockF1F32,300$96.30$221.49K98,094Direct
SaleAug 3, 2026
Common StockF1F4100$97.10$9.71K97,994Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.84 to $95.83, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.85 to $96.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  5. F5This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Aug 5, 2026Period of report Aug 3, 20260001636282-26-000099
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 3, 2026
Common StockF1F2F3800$93.97$75.18K581,740Direct
SaleAug 3, 2026
Common StockF1F4F37,157$95.10$680.63K574,583Direct
SaleAug 3, 2026
Common StockF1F5F35,635$95.93$540.57K568,948Direct
SaleAug 3, 2026
Common StockF1F6F31,392$96.82$134.77K567,556Direct
SaleAug 3, 2026
Common StockF1F7F316$97.46$1.56K567,540Direct
Filing footnotes · 7
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.42 to $94.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 58,108 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $94.44 to $95.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $95.45 to $96.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.45 to $97.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $97.46 to $97.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001636282-26-000088
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F25,775$87.55$505.60K99,719Direct
SaleJul 1, 2026
Common StockF1F3F41,725$88.37$152.44K97,994Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.13 to $88.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.17 to $89.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  5. F5This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Sheldon SloanChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001636282-26-000087
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F26,500$87.52$568.88K1,834Direct
SaleJul 1, 2026
Common StockF1F31,834$88.34$162.02K0Direct
Filing footnotes · 4
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.03 to $87.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.03 to $88.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4This option represents the right to purchase 400,000 shares of the Issuer's common stock, one quarter of which vested and became exercisable on October 1, 2025, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jul 1, 20260001636282-26-000086
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F310,176$87.44$889.79K587,364Direct
SaleJul 1, 2026
Common StockF1F4F34,234$88.12$373.10K583,130Direct
SaleJul 1, 2026
Common StockF1F5F3590$88.91$52.46K582,540Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.82 to $87.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 72,623 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $87.82 to $88.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $88.86 to $88.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4
Filed Jun 26, 2026Period of report Jun 25, 20260001853327-26-000008
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 25, 2026
Common Stock5,000$87.12$435.60K107,994Direct
SaleJun 25, 2026
Common StockF1F210,000$87.14$871.40K97,994Direct
Filing footnotes · 3
  1. F1The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.78 to $87.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  2. F2Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  3. F3This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Funds Management LLC FairmountDirector
Healthcare Fund II L.P. FairmountDirector
Peter Evan HarwinDirector
Tomas KiselakDirector
4
Filed Jun 23, 2026Period of report Jun 23, 20260001104659-26-076967
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 23, 2026
Common StockF24,684,781$85.31$399.66M0IndirectBy Fairmount Healthcare Fund II L.P.
Filing footnotes · 3
  1. F1Each share of Series B Preferred Stock is convertible at the option of the holder into 40 shares of Common Stock, subject to certain beneficial ownership limitations, including that a holder of Series B Preferred Stock is prohibited from converting shares of Series B Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. On June 23, 2026, the Reporting Persons converted 16,667 shares of Series B Preferred Stock into 666,680 shares of Common Stock for no cash consideration, in accordance with the Certificate of Designations for the Series B Convertible Preferred Stock.
  2. F2Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund II L.P. The managers of Fairmount are Peter Harwin and Tomas Kiselak. Fairmount, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
  3. F3Each share of Series A Preferred Stock is convertible at the option of the holder into 40 shares of Common Stock, subject to certain beneficial ownership limitations, including that a holder of Series A Preferred Stock is prohibited from converting shares of Series A Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than 9.99% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion.
Open on SEC EDGAR
Michael Thomas HendersonDirector
4Rule 10b5-1 plan disclosed
Filed Jun 23, 2026Period of report Jun 22, 20260001636282-26-000084
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 22, 2026
Common StockF120,000$100.00$2.00M68,606Direct
Filing footnotes · 1
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.
Open on SEC EDGAR
Sheldon SloanChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 3, 20260001636282-26-000078
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 3, 2026
Common StockF18,333$75.00$624.98K0Direct
Filing footnotes · 2
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2This option represents the right to purchase 400,000 shares of the Issuer's common stock, one quarter of which vested and became exercisable on October 1, 2025, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260001636282-26-000077
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F2F33,557$69.40$246.86K608,983Direct
SaleJun 1, 2026
Common StockF1F4F38,149$70.50$574.50K600,834Direct
SaleJun 1, 2026
Common StockF1F5F33,294$71.38$235.13K597,540Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.96 to $69.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 87,138 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.96 to $70.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.97 to $71.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260001636282-26-000076
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Common StockF1F21,801$69.75$125.62K103,693Direct
SaleJun 1, 2026
Common StockF1F32,599$70.77$183.93K101,094Direct
SaleJun 1, 2026
Common StockF1F4F53,100$72.06$223.39K97,994Direct
Filing footnotes · 6
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.37 to $70.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.38 to $71.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.54 to $72.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  6. F6This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Michael Thomas HendersonDirector
4Rule 10b5-1 plan disclosed
Filed May 8, 2026Period of report May 8, 20260001636282-26-000053
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 8, 2026
Common StockF1F22,404$72.57$174.46K166,202Direct
SaleMay 8, 2026
Common StockF1F333,513$73.72$2.47M132,689Direct
SaleMay 8, 2026
Common StockF1F424,814$74.76$1.86M107,875Direct
SaleMay 8, 2026
Common StockF1F519,269$75.35$1.45M88,606Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 6, 2026.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.03 to $73.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.15 to $74.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.15 to $75.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $75.15 to $75.71, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Sheldon SloanChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report May 1, 20260002038798-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF1F221,306$69.53$1.48M57,027Direct
SaleMay 1, 2026
Common StockF1F319,656$70.61$1.39M37,371Direct
SaleMay 1, 2026
Common StockF1F48,777$71.56$628.08K28,594Direct
SaleMay 1, 2026
Common StockF1F512,777$72.94$931.95K15,817Direct
SaleMay 1, 2026
Common StockF1F610,358$73.74$763.80K5,459Direct
SaleMay 1, 2026
Common StockF1F75,059$74.60$377.40K400Direct
SaleMay 1, 2026
Common StockF1400$75.37$30.15K0Direct
Filing footnotes · 8
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.21 to $70.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.21 to $71.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.21 to $72.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.21 to $73.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.21 to $74.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.21 to $74.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. F8This option represents the right to purchase 400,000 shares of the Issuer's common stock, one quarter of vested and became exercisable on October 1, 2025, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report May 1, 20260001853327-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF1F212,500$71.37$892.13K97,994Direct
Filing footnotes · 3
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  3. F3This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed May 1, 2026Period of report May 1, 20260001758363-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Common StockF1F2F35,300$69.54$368.56K622,240Direct
SaleMay 1, 2026
Common StockF1F4F33,600$70.77$254.77K618,640Direct
SaleMay 1, 2026
Common StockF1F5F31,000$71.76$71.76K617,640Direct
SaleMay 1, 2026
Common StockF1F6F33,100$73.14$226.73K614,540Direct
SaleMay 1, 2026
Common StockF1F7F31,700$74.23$126.19K612,840Direct
SaleMay 1, 2026
Common StockF1F8F3300$74.96$22.49K612,540Direct
Filing footnotes · 8
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $69.25 to $70.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 101,653 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.30 to $71.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.41 to $72.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  6. F6The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.75 to $73.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  7. F7The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $73.95 to $74.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  8. F8The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $74.95 to $74.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001853327-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF1F26,200$49.21$305.10K99,294Direct
SaleApr 1, 2026
Common StockF1F3F41,300$49.98$64.97K97,994Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.69 to $49.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.76 to $50.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  5. F5This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001758363-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF1F2F312,344$49.20$607.32K630,196Direct
SaleApr 1, 2026
Common StockF1F4F32,656$49.92$132.59K627,540Direct
Filing footnotes · 4
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.64 to $49.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 116,168 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.64 to $50.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Sheldon SloanChief Medical Officer
4Rule 10b5-1 plan disclosed
Filed Apr 3, 2026Period of report Apr 1, 20260001636282-26-000030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Common StockF17,958$50.00$397.90K0Direct
Filing footnotes · 2
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Open on SEC EDGAR
Scott L BurrowsChief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 3, 20260001636282-26-000028
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 3, 2026
Common StockF1F22,300$40.56$93.29K98,194Direct
SaleMar 3, 2026
Common StockF1F3F4200$41.66$8.33K97,994Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 10, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.17 to $41.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.55 to $41.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. F4Includes 67,476 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive, upon vesting, one share of Common Stock. The RSUs vest in two equal installments on each of September 1, 2026 and 2027, subject to the Reporting Person's continued employment with the Issuer.
  5. F5This option represents a right to purchase 404,857 shares of the Issuer's common stock (which have been adjusted to reflect the Issuer's 1-for-25 reverse stock split on September 8, 2023), one quarter of which vested and became exercisable on September 1, 2024, with the remaining three quarters vesting in monthly installments over the following three years, subject to the Reporting Person's continued employment with the Issuer.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Mar 3, 2026Period of report Mar 2, 20260001636282-26-000026
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 2, 2026
Common StockF1F2F35,900$41.73$246.21K651,640Direct
SaleMar 2, 2026
Common StockF1F4F39,100$42.49$386.66K642,540Direct
Filing footnotes · 4
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.23 to $42.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 130,683 shares of common stock that vest in monthly installments through November 2026, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.23 to $42.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Feb 4, 2026Period of report Feb 2, 20260001758363-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 2, 2026
Common StockF1F2F3F4957$31.82$30.45K671,583Direct
SaleFeb 2, 2026
Common StockF1F5F314,043$32.87$461.59K657,540Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.42 to $32.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 145,198 shares of common stock that vest in monthly installments over approximately one year, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4Includes 633 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on August 15, 2024.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.48 to $33.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jan 6, 2026Period of report Jan 2, 20260001758363-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 2, 2026
Common StockF1F2F312,709$30.47$387.24K674,198Direct
SaleJan 2, 2026
Common StockF1F4F32,191$31.79$69.65K672,007Direct
SaleJan 2, 2026
Common StockF1F5F3100$32.39$3.24K671,907Direct
Filing footnotes · 5
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.20 to $31.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 159,713 shares of common stock that vest in monthly installments over approximately one year, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.29 to $32.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. F5The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.34 to $32.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR
Cameron TurtleDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Dec 3, 2025Period of report Dec 1, 20250001758363-25-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 1, 2025
Common StockF1F2F310,995$28.73$315.89K690,912Direct
SaleDec 1, 2025
Common StockF1F4F34,005$29.83$119.47K686,907Direct
Filing footnotes · 4
  1. F1This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025.
  2. F2The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.45 to $29.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range.
  3. F3Includes 174,228 shares of common stock that vest in monthly installments over approximately one year, subject to the continuing service of the Reporting Person on each vesting date.
  4. F4The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $29.47 to $30.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.